Chronic leg ulcers are rare in young adults and generally indicate a vascular cause. We report a case of a 26-year-old man with leg ulcers of eight months duration. Doppler study indicated venous incompetence and a postphlebitic limb. However, as the distribution and number of ulcers was not consistent with stasis alone and no features of collagen vascular disease were noted, a hyperviscosity state was considered and confirmed with significantly elevated homocysteine level in the serum. Administration of vitamins B1, B2, B6 and B12, trimethyl-glycine, mecobalamine, folic acid and povidone iodine dressings with culture-directed antibiotic therapy led to a satisfactory healing of ulcers over a period of one month. Hyperhomocysteinemia must be considered in the differential diagnosis of leg ulcers in young individuals.
INTRODUCTION
he was in remission for six months. The ulcers began on the dorsum of the left foot, medial malleoli-medial Hyperhomocysteinemia is a disorder of methionine aspect of the knee and showed purulent discharge at metabolism and its metabolites (homocysteine, all times. He was treated by a dermatologist with homocysteine-cysteine complex and others). The topical betamethasone and topical beclomethasone accumulation of homocysteine and its metabolites is dipropionate, clotrimazole, neomycin and oral caused by disruption of any of the three interrelated antibiotics. He had a Doppler study carried out at the pathways of methionine metabolism. Deficiency in age of 19 years and was diagnosed to have deep vein the cystathionine B-synthase (CBS) enzyme, defective thrombosis and treated with acenocoumarol for one methylcobalamin synthesis or abnormality in year. methylene tetrahydrofolate reductase leads to accumulation of homocysteine in blood.
On examination, the patient was obese. He presented with multiple varicosities, discoloration and CASE REPORT cutaneous ulcers with surrounding induration on the left lower limb. There were 13 ulcers of which the A 26-year-old businessman presented with multiple biggest ulcer measured 3 x 8 cm in diameter with episodes of ulcerations over the left leg during the pale granulation, yellowish slough, greyish edge, a last 14 months. After the first episode 14 months back halo of erythema and induration [ Figure 1 ]. Similar lesions were seen on the medial malleoli, shin and multiple ulcers on the lateral aspect of the left foot [ Figure 2 ]. 
Culture from the ulcer grew Staphylococcus aureus and
Pseudomonas aeruginosa that were sensitive to a few antibiotics, of which ciprofloxacin 1g once daily for 10 days was chosen for treatment. The plasma homocysteine level was >50 (normal range 0-17) and hence a diagnosis of homocysteinemia was made. He received trimethyl glycine 500 mg, mecobalamine 500 mcg, folic acid 1 mg, pyridoxine hydrochloride 10 mg, ciprofloxacin and injections of vitamin B3, B12, vitamin C, niacinamide, acenocoumarol and dextropropoxyphen to relieve his pain. Povidone iodine dressings and collagen Type III dressings were done twice a week.
The ulcer on the medial aspect of the knee healed after four weeks with some atrophy and hyperpigmentation [ Figure 1a ]. At the time of ulceration some areas with erythema and overlying suppuration, erosions healed up without breaking down to ulcer. The ulcer in the region of medial malleoli had healed significantly at the end of six weeks. The multiple ulcers on the lateral aspect of the left foot had healed satisfactorily [ Figure 2a ]. The patient remains well one and a half years later.
DISCUSSION
Homocysteine is a sulfur-containing metabolite of methionine and hyperhomocysteinemia is a risk factor for atherosclerosis and venous thrombosis. [1] It can be caused by genetic disorders affecting the trans sulfuration or remethylation pathways of homocysteine metabolism, folic acid deficiency, vitamin B12 deficiency, renal failure, hypothyroidism, increasing age and smoking. [2] Hyperhomocysteinemia is a biochemical disorder resulting from deficiency of cystathionine-beta synthase. The metabolic effects include increased platelet aggregation, toxic damage to endothelial surfaces [3] and altered anti-thrombin III activity leading to thromboembolic phenomenon. The systemic effects are as follows: a) CVS: Myocardial infarction; [4] hypertension; stroke; [4] blindness, renal, portal or pulmonary embolism, deep vein thrombosis. b) Ocular: Ectopia lentis, myopia, retinal detachment c) Skeletal: Marfanoid habitus, osteopenia d) Skin: Malar flush, livedoid vasculitis, [5] canities e) CNS: Mental retardation, seizures and stroke. [6] Hyperhomocysteinemia is generally recognized as an independent risk factor for coronary, cerebral and peripheral atherosclerosis. There has recently been renewed interest in homocysteine metabolism because hyperhomocysteinemia has been associated with occlusive arterial disease and neural tube defects. Deficiency of the enzyme 5, 10-methylenetetrahydrofolate reductase results in hyperhomocysteinemia and a wide variety of neurological and vascular symptoms. Molecular genetic analysis of the enzyme has led to the identification of nine rare mutations associated with a severe deficiency phenotype as well as one common mutation (found in 35 to 40% of alleles in the general population) that is proposed as a risk factor in some forms of cardiovascular disease and in neural defects. [3] Folic acid acts by participating in the synthesis of DNA, RNA and proteins. It is necessary for DNA repair, replication maintaining integrity of genome. [7] Complications of hyperhomocysteinemia are inflammatory bowel disease, cerebral thrombosis, acute myocardial infarction, venous thrombosis and atherosclerosis. The associated disorders of hyperhomocysteinemia are thromboembolism, pulmonary embolism, schizophrenia, Parkinson's disease, stroke, diabetes mellitus, osteoporosis, scoliosis, kyphosis, spina bifida, lens dislocation, glaucoma and myopia. Strategies for the treatment of CBS deficiency include increasing residual enzyme activity by giving pyridoxine in those patients with vitamin responsive variants, reducing the load on the affected pathway with a low methionine diet and supplementing the diet with cysteine and giving betaine in order to utilize alternative pathways to remove homocysteine. [8] All patients with chronic multiple leg ulcers with features suggestive of other vascular phenomena such as deep vein thrombosis, venous ulcer, stasis dermatitis, ischemic heart disease, retinal artery occlusion, claudication and Raynaud's phenomenon should have plasma homocysteine level measured immaterial of the age of the patient. It should also be considered in patients in whom basic investigations for the common causes of leg ulcers are not conclusive. Given the low cost of investigation and the easy prevention with folic acid, plasma homocysteine must be measured in every patient with chronic leg ulcers as it may be a contributory and correctable if not a primary cause of chronic leg ulcers.
